Should Cytoreductive Treatment Be Performed Before Transplantation in Patients With High-Risk Myelodysplastic Syndrome?

被引：40
作者：
Alessandrino, Emilio Paolo [1 ,2 ]
Della Porta, Matteo Giovanni [1 ,2 ]
Pascutto, Cristiana [1 ,2 ]
Bacigalupo, Andrea [3 ]
Rambaldi, Alessandro [4 ]
机构：
[1] Policlin San Matteo, Fdn Ist Ricovero & Cure Carattere Sci, I-27100 Pavia, Italy
[2] Univ Pavia, I-27100 Pavia, Italy
[3] Osped San Martino Genova, Genoa, Italy
[4] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 21期
关键词：
STEM-CELL TRANSPLANTATION; ELDERLY-PATIENTS; PHASE-III; LEUKEMIA; CHEMOTHERAPY; AZACITIDINE; CARE;
D O I：
10.1200/JCO.2012.48.0525
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2761 / 2762
页数：3
相关论文
共 8 条
  • [1] WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome:: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)
    Alessandrino, Emilio Paolo
    Della Porta, Matteo Giovanni
    Bacigalupo, Andrea
    Van Lint, Maria Teresa
    Falda, Michele
    Onida, Francesco
    Bernardi, Massimo
    Iori, Anna Paola
    Rambaldi, Alessandro
    Cerretti, Raffaella
    Marenco, Paola
    Pioltelli, Pietro
    Malcovati, Luca
    Pascutto, Cristiana
    Oneto, Rosi
    Fanin, Renato
    Bosi, Alberto
    Levis, A.
    Rambaldi, A.
    Bandini, G.
    Casini, M.
    Rossi, G.
    Angelucci, E.
    Baronciani, D.
    La Nasa, G.
    Milone, G.
    Mordini, N.
    Guidi, S.
    Bosi, A.
    Bacigalupo, A.
    Van Lint, M. T.
    Corradini, P.
    Milani, R.
    Morra, E.
    Marenco, P.
    Deliliers, G. Lambretenghi
    Onida, F.
    Ciceri, F.
    Bernardi, M.
    Castagna, L.
    Narni, F.
    Pioltelli, P.
    Selleri, Carmine
    Scime, R.
    Iannitto, E.
    Musso, M.
    Alessandrino, E. P.
    Locatelli, F.
    Martelli, F.
    Visani, G.
    [J]. BLOOD, 2008, 112 (03) : 895 - 902
  • [2] Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes: A Study by the Societe Francaise de Greffe de Moelle et de Therapie-Cellulaire and the Groupe-Francophone des Myelodysplasies
    Damaj, Gandhi
    Duhamel, Alain
    Robin, Marie
    Beguin, Yves
    Michallet, Mauricette
    Mohty, Mohamad
    Vigouroux, Stephane
    Bories, Pierre
    Garnier, Alice
    El Cheikh, Jean
    Bulabois, Claude-Eric
    Huynh, Anne
    Bay, Jacques-Olivier
    Legrand, Faeyzeh
    Deconinck, Eric
    Fegueux, Nathalie
    Clement, Laurence
    Dauriac, Charles
    Maillard, Natacha
    Cornillon, Jerome
    Ades, Lionel
    Guillerm, Gaelle
    Schmidt-Tanguy, Aline
    Marjanovic, Zora
    Park, Sophie
    Rubio, Marie-Therese
    Marolleau, Jean-Pierre
    Garnier, Federico
    Fenaux, Pierre
    Yakoub-Agha, Ibrahim
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (36) : 4533 - 4540
  • [3] Haematopoietic stem cell transplantation for patients with myelodysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)
    de Witte, T
    Hermans, J
    Vossen, J
    Bacigalupo, A
    Meloni, G
    Jacobsen, N
    Ruutu, T
    Ljungman, P
    Gratwohl, A
    Runde, V
    Niederwieser, D
    van Biezen, A
    Devergie, A
    Cornelissen, J
    Jouet, JP
    Arnold, R
    Apperley, J
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (03) : 620 - 630
  • [4] Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
    Fenaux, Pierre
    Mufti, Ghulam J.
    Hellstrom-Lindberg, Eva
    Santini, Valeria
    Finelli, Carlo
    Giagounidis, Aristoteles
    Schoch, Robert
    Gattermann, Norbert
    Sanz, Guillermo
    List, Alan
    Gore, Steven D.
    Seymour, John F.
    Bennett, John M.
    Byrd, John
    Backstrom, Jay
    Zimmerman, Linda
    McKenzie, David
    Beach, C. L.
    Silverman, Lewis R.
    [J]. LANCET ONCOLOGY, 2009, 10 (03) : 223 - 232
  • [5] Allogeneic stem cell transplantation for elderly patients with myelodysplastic syndrome
    Kroeger, Nicolaus
    [J]. BLOOD, 2012, 119 (24) : 5632 - 5639
  • [6] Allogeneic Hematopoietic Stem-Cell Transplantation for Patients 50 Years or Older With Myelodysplastic Syndromes or Secondary Acute Myeloid Leukemia
    Lim, ZiYi
    Brand, Ronald
    Martino, Rodrigo
    van Biezen, Anja
    Finke, Juergen
    Bacigalupo, Andrea
    Beelen, Dietrich
    Devergie, Agnes
    Alessandrino, Emilio
    Willemze, Roel
    Ruutu, Tapani
    Boogaerts, Marc
    Falda, Michele
    Jouet, Jean-Pierre
    Niederwieser, Dietger
    Kroger, Nicolaus
    Mufti, Ghulam J.
    De Witte, Theo M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) : 405 - 411
  • [7] Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate-or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group
    Luebbert, Michael
    Suciu, Stefan
    Baila, Liliana
    Ruter, Bjorn Hans
    Platzbecker, Uwe
    Giagounidis, Aristoteles
    Selleslag, Dominik
    Labar, Boris
    Germing, Ulrich
    Salih, Helmut R.
    Beeldens, Filip
    Muus, Petra
    Pfluger, Karl-Heinz
    Coens, Corneel
    Hagemeijer, Anne
    Schaefer, Hans Eckart
    Ganser, Arnold
    Aul, Carlo
    de Witte, Theo
    Wijermans, Pierre W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) : 1987 - 1996
  • [8] Value of chemotherapy before allogeneic hematopoietic stem cell transplantation from an HLA-identical sibling donor for myelodysplastic syndrome
    Nakai, K
    Kanda, Y
    Fukuhara, S
    Sakamaki, H
    Okamoto, S
    Kodera, Y
    Tanosaki, R
    Takahashi, S
    Matsushima, T
    Atsuta, Y
    Hamajima, N
    Kasai, M
    Kato, S
    [J]. LEUKEMIA, 2005, 19 (03) : 396 - 401
1